Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, March 28, 2024 · 699,436,954 Articles · 3+ Million Readers

Report: Exploring Fundamental Drivers Behind Goldfield, Dicerna Pharmaceuticals, Deciphera Pharmaceuticals, WesBanco, Carolina Financial, and TriState Capital — New Horizons, Emerging Trends, and Upcoming Developments

NEW YORK, March 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Goldfield Corp. (NYSE:GV), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), WesBanco, Inc. (NASDAQ:WSBC), Carolina Financial Corporation (NASDAQ:CARO), and TriState Capital Holdings, Inc. (NASDAQ:TSC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

GV DOWNLOAD: http://Fundamental-Markets.com/register/?so=GV
DRNA DOWNLOAD:
http://Fundamental-Markets.com/register/?so=DRNA
DCPH DOWNLOAD:
http://Fundamental-Markets.com/register/?so=DCPH
WSBC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=WSBC
CARO DOWNLOAD:
http://Fundamental-Markets.com/register/?so=CARO
TSC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=TSC

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Goldfield Corp. (NYSE:GV), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), WesBanco, Inc. (NASDAQ:WSBC), Carolina Financial Corporation (NASDAQ:CARO), and TriState Capital Holdings, Inc. (NASDAQ:TSC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 21st, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

GOLDFIELD CORP. (GV) REPORT OVERVIEW

Goldfield's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Goldfield reported revenue of $29.61MM vs $31.75MM (down 6.74%) and basic earnings per share $0.14 vs $0.10 (up 40.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Goldfield reported revenue of $113.95MM vs $130.42MM (down 12.63%) and basic earnings per share $0.33 vs $0.51 (down 35.29%).

To read the full Goldfield Corp. (GV) report, download it here: http://Fundamental-Markets.com/register/?so=GV

-----------------------------------------

DICERNA PHARMACEUTICALS, INC. (DRNA) REPORT OVERVIEW

Dicerna Pharmaceuticals' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Dicerna Pharmaceuticals reported revenue of $1.42MM vs $0.13MM (up 966.17%) and basic earnings per share -$0.91 vs -$0.68. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Dicerna Pharmaceuticals reported revenue of $2.28MM vs $0.30MM (up 671.86%) and basic earnings per share -$3.66 vs -$2.87. Dicerna Pharmaceuticals is expected to report earnings on May 14th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.68. The estimated EPS forecast for the next fiscal year is -$1.81 and is expected to report on March 14th, 2019.

To read the full Dicerna Pharmaceuticals, Inc. (DRNA) report, download it here: http://Fundamental-Markets.com/register/?so=DRNA

-----------------------------------------

DECIPHERA PHARMACEUTICALS, INC. (DCPH) REPORT OVERVIEW

Deciphera Pharmaceuticals' Recent Financial Performance

Deciphera Pharmaceuticals is expected to report earnings on March 27th, 2018. The report will be for the fiscal period ending December 31st, 2017. The estimated EPS forecast for the next fiscal year is -$1.52 and is expected to report on March 27th, 2018.

To read the full Deciphera Pharmaceuticals, Inc. (DCPH) report, download it here: http://Fundamental-Markets.com/register/?so=DCPH

-----------------------------------------

WESBANCO, INC. (WSBC) REPORT OVERVIEW

WesBanco's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, WesBanco reported interest income of $84.85MM vs $80.82MM (up 4.99%) and basic earnings per share $0.36 vs $0.54 (down 33.33%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, WesBanco reported interest income of $332.42MM vs $286.10MM (up 16.19%) and basic earnings per share $2.15 vs $2.16 (down 0.46%). WesBanco is expected to report earnings on April 17th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.60. The estimated EPS forecast for the next fiscal year is $3.12 and is expected to report on January 22nd, 2019.

To read the full WesBanco, Inc. (WSBC) report, download it here: http://Fundamental-Markets.com/register/?so=WSBC

-----------------------------------------

CAROLINA FINANCIAL CORPORATION (CARO) REPORT OVERVIEW

Carolina Financial's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Carolina Financial reported interest income of $32.37MM vs $16.85MM (up 92.06%) and basic earnings per share $0.32 vs $0.42 (down 23.81%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Carolina Financial reported interest income of $95.09MM vs $60.91MM (up 56.10%) and basic earnings per share $1.75 vs $1.45 (up 20.69%). Carolina Financial is expected to report earnings on April 23rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.41. The estimated EPS forecast for the next fiscal year is $3.16 and is expected to report on January 23rd, 2019.

To read the full Carolina Financial Corporation (CARO) report, download it here: http://Fundamental-Markets.com/register/?so=CARO

-----------------------------------------

TRISTATE CAPITAL HOLDINGS, INC. (TSC) REPORT OVERVIEW

TriState Capital's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, TriState Capital reported interest income of $37.87MM vs $26.23MM (up 44.36%) and basic earnings per share $0.44 vs $0.27 (up 62.96%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, TriState Capital reported interest income of $134.30MM vs $98.31MM (up 36.60%) and basic earnings per share $1.38 vs $1.04 (up 32.69%). TriState Capital is expected to report earnings on April 19th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.26. The estimated EPS forecast for the next fiscal year is $1.89 and is expected to report on January 23rd, 2019.

To read the full TriState Capital Holdings, Inc. (TSC) report, download it here: http://Fundamental-Markets.com/register/?so=TSC

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release